# Erie Indemnity Co: overview

ERIE · Nasdaq · CIK 922621 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/erie.md) · [Financials](/companies/erie/financials.md) · [Filings](/companies/erie/filings.md) · [Insiders](/companies/erie/insiders.md)

Latest reported revenue: [$1.07bn](/filings/0001628280-26-068274.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-068274).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [924 d](/filings/0001628280-26-010666.md) | [989](/filings/0001628280-26-026866.md) | [1,060](/filings/0001628280-26-051079.md) | [1,067](/filings/0001628280-26-068274.md) | [951 d](/filings/0001628280-26-010666.md) | [1,012](/filings/0001628280-26-026866.md) | [1,090](/filings/0001628280-26-051079.md) | [1,070](/filings/0001628280-26-068274.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [18.1% d](/filings/0001628280-26-010666.md) | [15.3%](/filings/0001628280-26-026866.md) | [18.8%](/filings/0001628280-26-051079.md) | [19.6%](/filings/0001628280-26-068274.md) | [16.6% d](/filings/0001628280-26-010666.md) | [16.5%](/filings/0001628280-26-026866.md) | [18.7%](/filings/0001628280-26-051079.md) | [19.4%](/filings/0001628280-26-068274.md) |
| Net margin | % | [16.5% d](/filings/0001628280-26-010666.md) | [14.0%](/filings/0001628280-26-068274.md) | [16.5%](/filings/0001628280-26-068274.md) | [17.1%](/filings/0001628280-26-068274.md) | [6.7% d](/filings/0001628280-26-010666.md) | [14.9%](/filings/0001628280-26-068274.md) | [16.5%](/filings/0001628280-26-068274.md) | [17.0%](/filings/0001628280-26-068274.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [147 d](/filings/0001628280-26-010666.md) | [88.4](/filings/0001628280-26-026866.md) | [157 d](/filings/0001628280-26-051079.md) | [184 d](/filings/0001628280-26-068274.md) | [141 d](/filings/0001628280-26-010666.md) | [54.5](/filings/0001628280-26-026866.md) | [173 d](/filings/0001628280-26-051079.md) | [185 d](/filings/0001628280-26-068274.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,634](/filings/0000922621-24-000006.md) | [2,840](/filings/0000922621-25-000004.md) | [3,269](/filings/0001628280-26-010666.md) | [3,795](/filings/0001628280-26-010666.md) | [4,067](/filings/0001628280-26-010666.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.1%](/filings/0000922621-24-000006.md) | [13.2%](/filings/0000922621-25-000004.md) | [15.9%](/filings/0001628280-26-010666.md) | [17.8%](/filings/0001628280-26-010666.md) | [17.6%](/filings/0001628280-26-010666.md) |
| Net margin | % | [11.3%](/filings/0000922621-24-000006.md) | [10.5%](/filings/0000922621-25-000004.md) | [13.6%](/filings/0001628280-26-010666.md) | [15.8%](/filings/0001628280-26-010666.md) | [13.8%](/filings/0001628280-26-010666.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [254](/filings/0000922621-24-000006.md) | [299](/filings/0000922621-25-000004.md) | [289](/filings/0001628280-26-010666.md) | [486](/filings/0001628280-26-010666.md) | [571](/filings/0001628280-26-010666.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/erie/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [PNC Financial Services Group, Inc.](/funds/713676.md) | 2026-06-30 | $1.16bn | 4,826,778 |  | Reduced −82,256 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $401.5m | 1,674,602 |  | Added +93,436 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $392.2m | 1,635,926 |  | Added +5,243 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $344.6m | 1,437,522 |  | Added +54,495 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $266.4m | 1,111,008 |  | Added +5,119 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $261.6m | 1,091,087 |  | Added +94,541 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $215.0m | 899,461 |  | Added +37,438 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $205.2m | 855,984 |  | Added +91,995 |
| [ProShare Advisors LLC](/funds/1357955.md) | 2026-06-30 | $153.8m | 641,437 |  | Added +43,463 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $126.2m | 526,267 |  | Added +46,485 |

## Recent filings

[All 3,826 filings](/companies/erie/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:26 ET | [10-Q](/filings/0001628280-26-068274.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068274 |
| 2026-10-29 | 16:20 ET | [8-K](/filings/0001628280-26-068265.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-068265 |
| 2026-07-30 | 16:25 ET | [10-Q](/filings/0001628280-26-051079.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051079 |
| 2026-07-30 | 16:20 ET | [8-K](/filings/0001628280-26-051071.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-051071 |
| 2026-05-21 | 16:10 ET | [8-K](/filings/0001628280-26-037267.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-037267 |
| 2026-04-23 | 16:25 ET | [10-Q](/filings/0001628280-26-026866.md) | Quarterly report, period 2026-03-31 | 0001628280-26-026866 |
| 2026-04-23 | 16:20 ET | [8-K](/filings/0001628280-26-026857.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-026857 |
| 2026-02-23 | 16:26 ET | [10-K](/filings/0001628280-26-010666.md) | Annual report, period 2025-12-31 | 0001628280-26-010666 |
| 2026-02-23 | 16:20 ET | [8-K](/filings/0001628280-26-010640.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-010640 |
| 2026-02-20 | 13:00 ET | [8-K](/filings/0001628280-26-010105.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-010105 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-010666.md), filed Feb 23, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/5023f1eb-0852-4cd2-a694-b17096c06cd6)

## About the filer

- CIK: 922621
- Tickers: ERIE
- Exchange: Nasdaq
- SIC code: 6411 Insurance Agents, Brokers & Service
- State of incorporation: PA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:29 ET. No prices; not investment advice.